JP2011509257A5 - - Google Patents

Download PDF

Info

Publication number
JP2011509257A5
JP2011509257A5 JP2010541540A JP2010541540A JP2011509257A5 JP 2011509257 A5 JP2011509257 A5 JP 2011509257A5 JP 2010541540 A JP2010541540 A JP 2010541540A JP 2010541540 A JP2010541540 A JP 2010541540A JP 2011509257 A5 JP2011509257 A5 JP 2011509257A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
cla
ala
compounds
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010541540A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011509257A (ja
JP5575662B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/088660 external-priority patent/WO2009088939A2/en
Publication of JP2011509257A publication Critical patent/JP2011509257A/ja
Publication of JP2011509257A5 publication Critical patent/JP2011509257A5/ja
Application granted granted Critical
Publication of JP5575662B2 publication Critical patent/JP5575662B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010541540A 2008-01-02 2008-12-31 神経変性疾患を処置するための組成物および方法 Expired - Fee Related JP5575662B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1859408P 2008-01-02 2008-01-02
US61/018,594 2008-01-02
PCT/US2008/088660 WO2009088939A2 (en) 2008-01-02 2008-12-31 Compositions and methods for treating neurodegenerative diseases

Publications (3)

Publication Number Publication Date
JP2011509257A JP2011509257A (ja) 2011-03-24
JP2011509257A5 true JP2011509257A5 (enExample) 2012-01-19
JP5575662B2 JP5575662B2 (ja) 2014-08-20

Family

ID=40798719

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010541540A Expired - Fee Related JP5575662B2 (ja) 2008-01-02 2008-12-31 神経変性疾患を処置するための組成物および方法

Country Status (6)

Country Link
US (2) US8168675B2 (enExample)
EP (1) EP2237777A4 (enExample)
JP (1) JP5575662B2 (enExample)
KR (1) KR101417201B1 (enExample)
CN (1) CN101945653B (enExample)
WO (1) WO2009088939A2 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3174544B1 (en) 2014-07-31 2020-12-09 Universita' Degli Studi Di Cagliari Ester of a phospholipid with conjugated linoleic acid for the treatment of psychiatric disorders with neuroinflammatory and neurodegenerative basis
EP3903776A4 (en) * 2018-12-25 2022-10-05 Demencare Laboratory Inc. COMPOSITION FOR IMPROVING COGNITIVE FUNCTIONS
KR102557719B1 (ko) * 2019-04-26 2023-07-20 가톨릭대학교 산학협력단 항산화제가 담지된 나노입자를 유효성분으로 포함하는 귀 질환 치료용 약학 조성물
CN113892460A (zh) * 2021-09-29 2022-01-07 滨州医学院 Nod-b6重组近交系小鼠模型的构建方法及应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2543587B2 (ja) * 1989-01-05 1996-10-16 帝人株式会社 語音聴力改善剤
US5670539A (en) * 1993-07-21 1997-09-23 New York State Office Of Mental Health Treatment of movement disorders using large neutral amino acids
US5977162A (en) * 1996-09-16 1999-11-02 Seidman; Michael D. Therapeutic treatment for auditory function
IT1290907B1 (it) * 1997-01-31 1998-12-14 Idi Farmaceutici Spa Composizione per prodotto dietetico efficace nel combattere lo stress ossidativo e il decadimento cellulare.
US6080788A (en) * 1997-03-27 2000-06-27 Sole; Michael J. Composition for improvement of cellular nutrition and mitochondrial energetics
GB0003310D0 (en) * 2000-02-15 2000-04-05 Univ Sheffield Bone formation
US6469049B1 (en) * 2000-04-21 2002-10-22 The United States Of America As Represented By The Secretary Of The Army Method of treating, preventing or inhibiting central nervous system injuries and diseases
DE10027968A1 (de) * 2000-06-08 2001-12-13 Asta Medica Ag Mittel zur Therapie von Demenzen
CN1105097C (zh) * 2000-09-14 2003-04-09 国家海洋局第一海洋研究所 微囊化共轭亚油酸
US20030045541A1 (en) * 2001-07-23 2003-03-06 Christopher Bruckner GABA-Receptor modulators with NMDA-Antagonistic activity
US6620850B2 (en) * 2001-09-19 2003-09-16 University Of Florida Materials and methods for treatment of neurological disorders involving overactivation of glutamatergic ionotropic receptors
US7438903B2 (en) * 2003-06-06 2008-10-21 Nbty, Inc. Methods and compositions that enhance bioavailability of coenzyme-Q10
US20050107338A1 (en) * 2003-11-17 2005-05-19 Seidman Michael D. Nutritional supplement enhancing mitochondrial function
AR048335A1 (es) * 2004-03-24 2006-04-19 Chugai Pharmaceutical Co Ltd Agentes terapeuticos para trastornos del oido interno que contienen un antagonista de il- 6 como un ingrediente activo
US7901675B2 (en) * 2004-10-13 2011-03-08 U.S. Department Of Veterans Affairs Method of using coenzyme Q10 to treat Huntington's disease
JP2006151909A (ja) * 2004-11-30 2006-06-15 Rohto Pharmaceut Co Ltd 内服用組成物
CN1850065A (zh) * 2005-04-23 2006-10-25 中山市尤利卡天然药物有限公司 口服共轭亚油酸及其衍生物用于增肌健体与皮肤美容的用途
JP2007023028A (ja) * 2005-06-16 2007-02-01 Ono Pharmaceut Co Ltd 内耳疾患治療剤
JP2006212021A (ja) * 2005-08-05 2006-08-17 Ajinomoto Co Inc 食品組成物
US20080234197A1 (en) * 2007-03-19 2008-09-25 Undurti N Das Method(s) of stabilizing and potentiating the actions and administration of brain-derived neurotrophic factor (BDNF)

Similar Documents

Publication Publication Date Title
JP5074661B2 (ja) 肝癌発生・進展抑制剤
JP7525868B2 (ja) アルカリ性化剤による血液浄化
JP2014528474A5 (enExample)
CA2549801A1 (en) Use of treprostinil to improve kidney functions
JP2013521310A5 (enExample)
JP2010531351A5 (enExample)
WO2008030830A3 (en) Sustained-release composition and method of use thereof
CA2855469A1 (en) Compositions and methods for nutritional supplementation
US12478598B2 (en) Compositions including cinnamic acid and methods of use thereof
US20250082597A1 (en) Method for treating tauopathy in the brain, brain stem and spinal column
JP2011509257A5 (enExample)
CN104667283A (zh) 一种治疗血脂异常和动脉粥样硬化的复方药物组合
JPWO2018193752A1 (ja) アルカリ性化剤による血液浄化
US20110117070A1 (en) Compositions and methods for treating headache
ITRM990483A1 (it) Composizione per la prevenzione e cura delle disfunzioni e patologie renali di tipo tossico e funzionale.
JP4355967B2 (ja) 医薬組成物
US20180318280A1 (en) Modified release nicotinamide
JP2008535907A5 (enExample)
WO2006043336A1 (ja) 胃粘膜疾患の治療又は予防のための組成物
JP2018529747A5 (enExample)
WO2018202704A1 (en) Nicotinamide for treating dyslipidemia
JP2015500836A5 (enExample)
JP5452042B2 (ja) 医薬組成物
TW201907948A (zh) 組成物
US7901675B2 (en) Method of using coenzyme Q10 to treat Huntington's disease